Regeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...

The market expects Regeneron (REGN) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...

Investors will focus on profits from asthma drug Dupixent and sales of Eylea HD when biotech giant Regeneron Pharmaceuticals, ...

What To Expect From Tesla After Musk Returned From D.O.G.E. Here's a closer look at what the Street is expecting.

Molina cuts 2025 earnings outlook again on ACA, Medicaid pressures The California-based insurer outlined its plans to survive what CEO Joe Zubretsky deemed a “season of great uncertainty.” ...